Montreal’s pharmaceutical industry has been hit hard by lab closings and layoffs, but the Canadian CEO of French drug giant Sanofi sees a possible cure. Christopher Viehbacher states that Canada needs to better protect intellectual property and must also adapt quickly to the downsizing of in-house research.

Sanofi head sees cures for what ails Canada’s pharma sector
Intellectual property safeguards, more research, tighter partnerships among universities, biotech firms and pharmaceutical firms all steps in right direction, Viehbacher argues


Comments are closed.